News & Updates

Does using GLP-1 RAs induce suicide in T2D patients?
Does using GLP-1 RAs induce suicide in T2D patients?
08 Mar 2025 byStephen Padilla

Patients with type 2 diabetes (T2D) who use glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) appear to have no increased risk of suicidality when compared with the use of dipeptidyl peptidase-4 inhibitors (DPP-4is) or sodium-glucose cotransporter-2 inhibitors (SGLT-2is), a study has found.

Does using GLP-1 RAs induce suicide in T2D patients?
08 Mar 2025
COVID-19 ups AIBD risk, but vaccination helps
COVID-19 ups AIBD risk, but vaccination helps
06 Mar 2025 byStephen Padilla

Individuals with COVID-19 infection are at higher risk of autoimmune blistering disease (AIBD), but vaccination helps reduce such risk, suggests a study.

COVID-19 ups AIBD risk, but vaccination helps
06 Mar 2025